Teva
In David Einhorn's portfolio · Greenlight Capital
Ticker TEVA
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Greenlight Capital 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2026 | Sell | 0 | |
| Q2 2026 | Reduce 1% | 2,886,059 | 2.5% |
| Q1 2026 | Reduce 5% | 2,910,729 | 2.7% |
| Q4 2025 | Reduce 19% | 3,058,734 | 3.4% |
| Q3 2025 | No change | 3,778,777 | 3.0% |
| Q2 2025 | Add 565% | 3,778,777 | 2.7% |
| Q1 2025 | Add 21% | 568,200 | 0.4% |
| Q4 2024 | Add 44% | 468,550 | 0.5% |
| Q3 2024 | No change | 324,850 | 0.2% |
| Q2 2024 | No change | 324,850 | 0.3% |
| Q1 2024 | Add 21% | 324,850 | 0.2% |
| Q4 2023 | Buy | 268,470 | 0.1% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.